Skip to main content
. 2021 Oct 5;28(5):3978–3986. doi: 10.3390/curroncol28050338

Figure 1.

Figure 1

(a) Overall survival outcomes by era of novel therapy; (b) overall survival outcomes by era in BRAF mutant-melanoma; (c) overall survival outcomes by era in unknown or wild-type BRAF mutation status.